The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
If you can cut, you can also start pasting. You can cut out genes that are limiting the that you don't you don't want to be in a cell. You can start pasting in sequences to replace mutations that cause disease. We can start pasting in big sequences like the sequence for cars or other types of things that will make TE- cells more powerful.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
And that is the basis for my ongoing work. We've put a lot of work over the years into being able to now take crisper technology, get it to work in TE-C cells to learn the rules about what are the genetic changes that will be most effective at making TE- cells into into amunotherapies that cure patients for with different diseases and then to go all the way and then actually use crisper to make tea cells that can be input into patients with new levels of precision and power and that's that's in clinical trials now.